These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35333330)

  • 1. Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes.
    Kaur S; Tam NY; McDonough MA; Schofield CJ; Aik WS
    Nucleic Acids Res; 2022 Apr; 50(7):4148-4160. PubMed ID: 35333330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct RNA
    Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5.
    Zou S; Toh JD; Wong KH; Gao YG; Hong W; Woon EC
    Sci Rep; 2016 May; 6():25677. PubMed ID: 27156733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of the human RNA demethylase Alkbh5 reveal basis for substrate recognition.
    Feng C; Liu Y; Wang G; Deng Z; Zhang Q; Wu W; Tong Y; Cheng C; Chen Z
    J Biol Chem; 2014 Apr; 289(17):11571-11583. PubMed ID: 24616105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 and ALKBH5 oppositely regulate m
    Song H; Feng X; Zhang H; Luo Y; Huang J; Lin M; Jin J; Ding X; Wu S; Huang H; Yu T; Zhang M; Hong H; Yao S; Zhao Y; Zhang Z
    Autophagy; 2019 Aug; 15(8):1419-1437. PubMed ID: 30870073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme.
    Takahashi H; Hase H; Yoshida T; Tashiro J; Hirade Y; Kitae K; Tsujikawa K
    Chem Biol Drug Des; 2022 Jul; 100(1):1-12. PubMed ID: 35384315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of formaldehyde dehydrogenase-coupled assay and antibody-based assays for ALKBH5 activity evaluation.
    Shen DD; Suo FZ; Song QM; Chang J; Zhang T; Hong JJ; Zheng YC; Liu HM
    J Pharm Biomed Anal; 2019 Jan; 162():9-15. PubMed ID: 30219599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molecular Basis of Human ALKBH3 Mediated RNA N
    Zhang L; Duan HC; Paduch M; Hu J; Zhang C; Mu Y; Lin H; He C; Kossiakoff AA; Jia G; Zhang L
    Angew Chem Int Ed Engl; 2024 Feb; 63(7):e202313900. PubMed ID: 38158383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Flavin Mononucleotide as a Cell-Active Artificial N
    Xie LJ; Yang XT; Wang RL; Cheng HP; Li ZY; Liu L; Mao L; Wang M; Cheng L
    Angew Chem Int Ed Engl; 2019 Apr; 58(15):5028-5032. PubMed ID: 30756480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased
    Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
    Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a potent, selective and cell active inhibitor of m
    Fang Z; Mu B; Liu Y; Guo N; Xiong L; Guo Y; Xia A; Zhang R; Zhang H; Yao R; Fan Y; Li L; Yang S; Xiang R
    Eur J Med Chem; 2022 Aug; 238():114446. PubMed ID: 35597008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
    Qu J; Yan H; Hou Y; Cao W; Liu Y; Zhang E; He J; Cai Z
    J Hematol Oncol; 2022 Jan; 15(1):8. PubMed ID: 35063010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Differentiation and Aging Lead To Up-Regulation of FTO, While the ALKBH5 Protein Level Was Stable During Aging but Up-Regulated During in vitro-Induced Cardiomyogenesis.
    Krejčí J; Arcidiacono OA; Čegan R; Radaszkiewicz K; Pacherník J; Pirk J; Pešl M; Fila P; Bártová E
    Physiol Res; 2023 Aug; 72(4):425-444. PubMed ID: 37795886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.
    Zhang X; Wei LH; Wang Y; Xiao Y; Liu J; Zhang W; Yan N; Amu G; Tang X; Zhang L; Jia G
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2919-2924. PubMed ID: 30718435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation.
    Xu C; Liu K; Tempel W; Demetriades M; Aik W; Schofield CJ; Min J
    J Biol Chem; 2014 Jun; 289(25):17299-311. PubMed ID: 24778178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
    Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.